Search

everythinglearnresearchcommunity

for

Search:↓

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Effective treatments for common hair loss are limited and may have side effects, leading to patient disappointment and treatment discontinuation.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Mesotherapy lacks strong evidence for effectiveness and safety, and its ingredients are not FDA-approved for subcutaneous use.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Low-speed protocols with certified centrifuges and FDA-approved glass tubes are best for effective PRF outcomes.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

Lasers might help hair growth in some alopecia cases, but more research is needed to confirm their effectiveness and safety.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Oral medication is necessary to treat scalp fungus in children, with griseofulvin being the usual choice.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

Six African American women experienced hair loss after switching to a new HIV medication.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

A man developed a serious muscle breakdown condition after using a hair loss medication not known to cause this side effect.

Accidental findings have led to new hair treatment discoveries, like using blood pressure and diabetes medications for hair loss and unwanted hair.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Lasers in hair transplantation show promise but are not yet standard, with current methods causing some side effects and needles still being preferred for creating recipient sites.